Compare FSV & STVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | FSV | STVN |
|---|---|---|
| Founded | 1988 | 1949 |
| Country | Canada | Italy |
| Employees | N/A | N/A |
| Industry | Real Estate | Containers/Packaging |
| Sector | Finance | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.2B | 7.4B |
| IPO Year | N/A | 2021 |
| Metric | FSV | STVN |
|---|---|---|
| Price | $162.14 | $19.88 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 4 | 2 |
| Target Price | ★ $214.25 | $23.75 |
| AVG Volume (30 Days) | 203.6K | ★ 287.2K |
| Earning Date | 02-04-2026 | 03-05-2026 |
| Dividend Yield | ★ 0.68% | 0.30% |
| EPS Growth | ★ 26.06 | 19.61 |
| EPS | ★ 3.03 | 0.60 |
| Revenue | ★ $5,479,473,000.00 | $1,373,219,524.00 |
| Revenue This Year | $6.04 | $8.42 |
| Revenue Next Year | $6.89 | $9.61 |
| P/E Ratio | $53.75 | ★ $35.13 |
| Revenue Growth | ★ 11.13 | 6.97 |
| 52 Week Low | $147.23 | $17.81 |
| 52 Week High | $209.66 | $28.00 |
| Indicator | FSV | STVN |
|---|---|---|
| Relative Strength Index (RSI) | 59.26 | 38.77 |
| Support Level | $156.00 | $20.19 |
| Resistance Level | $163.91 | $21.23 |
| Average True Range (ATR) | 3.39 | 0.76 |
| MACD | 0.95 | -0.00 |
| Stochastic Oscillator | 86.66 | 0.00 |
FirstService Corp operates in two business divisions: FirstService Residential and FirstService Brands. FirstService Residential has service contracts to manage thousands of residential communities, including high-, medium-, and low-rise condominiums and co-operatives. FirstService Brands generates the majority of the company's revenue and provides property services to residential and commercial customers through the following brands: California Closets; Paul Davis Restoration; CertPro Painters; Pillar to Post; Floor Coverings International; College Pro Painters; and Service America. The company earns the majority of its revenue in the United States, with the remaining revenue generated in Canada.
Stevanato Group SpA is a provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries. It delivers an integrated, end-to-end portfolio of products, processes, and services that address customer needs across the entire drug life cycle including development, clinical, and commercial stages. It has two segments; Biopharmaceutical and Diagnostic Solutions which generates key revenue, includes all the products, processes and services developed and provided for the containment and delivery of pharmaceutical and biotechnology drugs and reagents, as well as the production of diagnostic consumables and its other segment is Engineering. Geographically, the company derives majority revenue from Europe, Middle East and Africa.